XERS - Xeris Pharmaceuticals misses by $0.26 beats on revenue May, 09 2019 05:16 PM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (NASDAQ:XERS): Q1 GAAP EPS of -$1.07 misses by $0.26.Revenue of $0.25M (-3.8% Y/Y) beats by $0.18M.Press ReleaseMore news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,